肿瘤医生应该如何拥抱基因组学?ASCO有话说!

JOURNAL OF CLINICAL ONCOLOGY

2017-07-24Article

24.008

影响因子

原标题:肿瘤医生需要识别健康信息技术以促进采纳基因组医学:来自2016年美国临床肿瘤学会(ASCO)组学和精准肿瘤学研讨会的建议

① 2016年5月ASCO召开数据标准化和互用性峰会,全体一致同意肿瘤临床实践中四个方面有健康信息技术方面的需求,包括组学和精准肿瘤学、先进的互用性、患者参与和价值基础上的肿瘤学;② 存在缺乏单一通用互用性标准,目前的电子健康记录(EHR)缺乏基因组数据,缺乏标准化命名规划等缺陷;③ ASCO组学和精准肿瘤学研讨会提出必须开发基因组临床决策支持(CDS)工具,应快速制订传输基因组信息的全面的通用标准等一系列重要推荐。

数据标准化 电子健康记录(EHR) 精准肿瘤学 组学

图片

Title:
Identifying Health Information Technology Needs of Oncologists to Facilitate the Adoption of Genomic Medicine: Recommendations From the 2016 American Society of Clinical Oncology Omics and Precision Oncology Workshop

DOI:
10.1200/JCO.2017.74.1744

Abstract & Authors展开

Abstract:
At the ASCO Data Standards and Interoperability Summit held in May 2016, it was unanimously decided that four areas of current oncology clinical practice have serious, unmet health information technology needs. The following areas of need were identified: 1) omics and precision oncology, 2) advancing interoperability, 3) patient engagement, and 4) value-based oncology. To begin to address these issues, ASCO convened two complementary workshops: the Omics and Precision Oncology Workshop in October 2016 and the Advancing Interoperability Workshop in December 2016. A common goal was to address the complexity, enormity, and rapidly changing nature of genomic information, which existing electronic health records are ill equipped to manage. The subject matter experts invited to the Omics and Precision Oncology Workgroup were tasked with the responsibility of determining a specific, limited need that could be addressed by a software application (app) in the short-term future, using currently available genomic knowledge bases. Hence, the scope of this workshop was to determine the basic functionality of one app that could serve as a test case for app development. The goal of the second workshop, described separately, was to identify the specifications for such an app. This approach was chosen both to facilitate the development of a useful app and to help ASCO and oncologists better understand the mechanics, difficulties, and gaps in genomic clinical decision support tool development. In this article, we discuss the key challenges and recommendations identified by the workshop participants. Our hope is to narrow the gap between the practicing oncologist and ongoing national efforts to provide precision oncology and value-based care to cancer patients.

All Authors:
Kevin S Hughes,Edward P Ambinder,Gregory P Hess,Peter Paul Yu,Elmer V Bernstam,Mark J Routbort,Jean Rene Clemenceau,John T Hamm,Phillip G Febbo,Susan M Domchek,James L Chen,Jeremy L Warner

First Authors:
Kevin S Hughes

Correspondence:
Jeremy L Warner

查看PDF原文

已完成

请稍等...

提示
提示